Finance

Lists
DGX:NYSE
Quest Diagnostics Inc
၂၃၃.၄၃ US$
+၁.၂၉%
(+၂.၉၇) 1D
၂၃၅.၃၀ US$
+၀.၈၀% (+၁.၈၇)
Pre-market
Closed: အောက် ၁၄, GMT-၄ ၁၆:၀၂:၅၈  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DGX...
Open
၂၃၁.၃၂ US$
High
၂၃၄.၉၇ US$
Low
၂၃၁.၃၂ US$
Mkt. cap
ဋေ ၂.၅၈ ထ
Avg. vol.
၁.၁၀ သန်း
Volume
၁.၆၁ ထောင်
Dividend
၁.၄၇%
Quarterly dividend
၀.၈၆ US$
Ex-dividend date
၂၀၂၆ အောက် ၆
P/E ratio
၂၄.၈၁
52-wk high
၂၄၈.၈၄ US$
52-wk low
၁၇၁.၁၈ US$
EPS
၉.၄၁ US$
Beta
၀.၅၄
Shares outstanding
၁၁.၀၄ ကုဋေ
No. of employees
၅ သောင်း
Open
၂၃၁.၃၂ US$
High
၂၃၄.၉၇ US$
Low
၂၃၁.၃၂ US$
Mkt. cap
ဋေ ၂.၅၈ ထ
Avg. vol.
၁.၁၀ သန်း
Volume
၁.၆၁ ထောင်
Dividend
၁.၄၇%
Quarterly dividend
၀.၈၆ US$
Ex-dividend date
၂၀၂၆ အောက် ၆
P/E ratio
၂၄.၈၁
52-wk high
၂၄၈.၈၄ US$
52-wk low
၁၇၁.၁၈ US$
EPS
၉.၄၁ US$
Beta
၀.၅၄
Shares outstanding
၁၁.၀၄ ကုဋေ
No. of employees
၅ သောင်း
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၆ နာရီ
Quest Diagnostics Incorporated (DGX) Stock Forecasts
Zacks
Zacks
·
ပြီးခဲ့သည့် ၂၁ နာရီ
Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings
Profile
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing. Wikipedia
About Quest Diagnostics Inc
CEOJames E. Davis
Employees၅.၁၅ သောင်း
Founded၁၉၆၇
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 11 analysts giving stock ratings to DGX in the past 3 months
Buy
Buy
7
Hold
4
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for DGX in the last 3 months.
Highest
Current ၂၃၃.၄၃ US$
၂၆၅.၀၀ US$ (+၁၃.၅၂%)
Average
၂၅၆.၀၀ US$ (+၉.၆၇%)
Lowest
၂၄၅.၀၀ US$ (+၄.၉၆%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luke Sergott
Barclays
Buy
Maintained
၂၆၀.၀၀ US$
+၁၁.၄%
10/07/2026
David S Macdonald
Truist Financial
Hold
Reiterated
၂၆၀.၀၀ US$
+၁၁.၄%
09/22/2026
Kevin Caliendo
UBS
Hold
Maintained
၂၄၅.၀၀ US$
+၅%
09/08/2026
Erin Wright
Morgan Stanley
Buy
Maintained
၂၆၀.၀၀ US$
+၁၁.၄%
08/19/2026
David Toung
Argus Research
Buy
Maintained
၂၆၀.၀၀ US$
+၁၁.၄%
07/28/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
၂၆၀.၀၀ US$
+၁၁.၄%
07/28/2026
Lisa Gill
J.P. Morgan
Hold
Reiterated
၂၅၀.၀၀ US$
+၇.၁%
07/28/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
၂၆၅.၀၀ US$
+၁၃.၅%
07/24/2026
Eric Coldwell
Robert W. Baird
Hold
Maintained
၂၅၅.၀၀ US$
+၉.၂%
07/24/2026
Tycho Peterson
Jefferies
Buy
Reiterated
၂၄၅.၀၀ US$
+၅%
07/23/2026
Jared Haase
William Blair
Buy
Maintained
-
-
07/23/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
06/15/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
၂၁၀.၀၀ US$
-၁၀%
04/20/2026
Patrick B Donnelly
Citi
Hold
Maintained
၂၁၅.၀၀ US$
-၇.၉%
02/11/2026
Next call ၇ ရက်အတွင်း
အောက် ၂၂ ကြာသပတေး, ၁၄:၃၀
Fiscal period
Q3 2026
- / ၂.၈၇ US$
Revenue / Est. (USD)
- / ၃၀၄.၉၉ ဋေ
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၂၈၁.၆၀ ဋေ
၂၈၀.၆၀ ဋေ
၂၈၉.၅၀ ဋေ
၃၀၄.၃၀ ဋေ
Cost of goods sold
၁၈၆.၅၀ ဋေ
၁၈၉.၁၀ ဋေ
၁၉၅.၁၀ ဋေ
၂၀၁.၅၀ ဋေ
Cost of revenue
၁၈၆.၅၀ ဋေ
၁၈၉.၁၀ ဋေ
၁၉၅.၁၀ ဋေ
၂၀၁.၅၀ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄၉.၁၀ ကုဋေ
၄၈.၆၀ ကုဋေ
၄၉.၈၀ ကုဋေ
၅၂.၆၀ ကုဋေ
Operating expense
၅၃.၁၀ ကုဋေ
၅၂.၃၀ ကုဋေ
၅၃.၃၀ ကုဋေ
၅၆.၄၀ ကုဋေ
Total operating expenses
၂၃၉.၆၀ ဋေ
၂၄၁.၄၀ ဋေ
၂၄၈.၄၀ ဋေ
၂၅၇.၉၀ ဋေ
Operating income
၄၂.၀၀ ကုဋေ
၃၉.၂၀ ကုဋေ
၄၁.၁၀ ကုဋေ
၄၆.၄၀ ကုဋေ
Other non operating income
၈.၀၀ သန်း
၉.၀၀ သန်း
-၂.၀၀ သန်း
၁.၆၀ ကုဋေ
EBT including unusual items
၃၃.၆၀ ကုဋေ
၃၃.၇၀ ကုဋေ
၃၃.၈၀ ကုဋေ
၄၂.၂၀ ကုဋေ
EBT excluding unusual items
၃၇.၀၀ ကုဋေ
၃၄.၄၀ ကုဋေ
၃၅.၀၀ ကုဋေ
၄၂.၇၀ ကုဋေ
Income tax expense
၇.၇၀ ကုဋေ
၈.၁၀ ကုဋေ
၇.၄၀ ကုဋေ
၈.၈၀ ကုဋေ
Effective tax rate
၂၂.၉၂%
၂၄.၀၄%
၂၁.၈၉%
၂၀.၈၅%
Other operating expenses
၁.၀၀ သန်း
-
-၂.၀၀ သန်း
-
Net income
၂၄.၅၀ ကုဋေ
၂၄.၅၀ ကုဋေ
၂၅.၂၀ ကုဋေ
၃၂.၀၀ ကုဋေ
Net profit margin
၈.၇၀%
၈.၇၃%
၈.၇၀%
၁၀.၅၂%
Earnings per share
၂.၆၀
၂.၄၂
၂.၅၀
၃.၁၂
Interest and investment income
၃.၀၀ သန်း
၃.၀၀ သန်း
၂.၀၀ သန်း
၅.၀၀ သန်း
Interest expense
-၆.၉၀ ကုဋေ
-၆.၇၀ ကုဋေ
-၆.၅၀ ကုဋေ
-၆.၈၀ ကုဋေ
Net interest expenses
-၆.၆၀ ကုဋေ
-၆.၄၀ ကုဋေ
-၆.၃၀ ကုဋေ
-၆.၃၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၅၆.၂၀ ကုဋေ
၅၃.၇၀ ကုဋေ
၅၅.၈၀ ကုဋေ
၆၁.၀၀ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ